Home
LVTX
LVTX News

Latest LAVA Therapeutics N.V. (LVTX) News on November 25, 2025

MT Newswires

4 days ago

Xoma Royalty Completes Acquisition of Lava Therapeutics

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

GlobeNewswire

4 days ago

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq

GlobeNewswire

12 days ago

LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

GlobeNewswire

13 days ago

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline

GlobeNewswire

15 days ago

LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline

MT Newswires

a month ago

XOMA Royalty Lowers Cash Offer for Lava Therapeutics, Extends Tender Deadline

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

GlobeNewswire

a month ago

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

Here's Why We're Watching LAVA Therapeutics' (NASDAQ:LVTX) Cash Burn Situation

Simply Wall St.

6 months ago

Here's Why We're Watching LAVA Therapeutics' (NASDAQ:LVTX) Cash Burn Situation

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

GlobeNewswire

6 months ago

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

GlobeNewswire

7 months ago

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

GlobeNewswire

8 months ago

LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

LAVA Announces Evaluation of Strategic Options

GlobeNewswire

9 months ago

LAVA Announces Evaluation of Strategic Options

LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers

GlobeNewswire

10 months ago

LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers

LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027

GlobeNewswire

a year ago

LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027

LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

LAVA Reports Second Quarter 2024 Financial Results and Business Update

GlobeNewswire

a year ago

LAVA Reports Second Quarter 2024 Financial Results and Business Update

LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

GlobeNewswire

a year ago

LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

LAVA Announces Annual Meeting of Shareholders

GlobeNewswire

a year ago

LAVA Announces Annual Meeting of Shareholders

LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference

LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results

GlobeNewswire

2 years ago

LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results

LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference

GlobeNewswire

2 years ago

LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference

LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint

Simply Wall St.

2 years ago

LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint

LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results

GlobeNewswire

2 years ago

LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results

LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)

GlobeNewswire

2 years ago

LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)

First Savings Financial (FSFG) Tops Q1 Earnings Estimates

Zacks

2 years ago

First Savings Financial (FSFG) Tops Q1 Earnings Estimates

FNCB Bancorp, Inc. Announces Fourth Quarter and Year to Date 2023 Earnings

GlobeNewswire

2 years ago

FNCB Bancorp, Inc. Announces Fourth Quarter and Year to Date 2023 Earnings

Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion

GlobeNewswire

2 years ago

Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

GlobeNewswire

2 years ago

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

Lifetime Brands (NASDAQ:LCUT) Is Due To Pay A Dividend Of $0.0425

Simply Wall St.

2 years ago

Lifetime Brands (NASDAQ:LCUT) Is Due To Pay A Dividend Of $0.0425

LiveOne's Subsidiary LiveOne Brands' Birthday Sex Wine Sells Out in First Week of Pre-Sale

NewMediaWire

2 years ago

LiveOne's Subsidiary LiveOne Brands' Birthday Sex Wine Sells Out in First Week of Pre-Sale

ContextLogic Inc.'s (NASDAQ:WISH) top owners are individual investors with 45% stake, while 44% is held by institutions

Simply Wall St.

2 years ago

ContextLogic Inc.'s (NASDAQ:WISH) top owners are individual investors with 45% stake, while 44% is held by institutions

Business Wire

2 years ago

Franklin Templeton Closed-End Funds Announce Share Repurchases for the Fourth Quarter of 2023

Why Syros Pharmaceuticals (SYRS) Stock Might be a Great Pick

Zacks

2 years ago

Why Syros Pharmaceuticals (SYRS) Stock Might be a Great Pick

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

GlobeNewswire

2 years ago

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

ICZOOM Announces SaaS Enhancement of One-Stop Components Procurement Platform to Support Customer Growth

PR Newswire

2 years ago

ICZOOM Announces SaaS Enhancement of One-Stop Components Procurement Platform to Support Customer Growth

Independent Director of Unifi Picks Up 28% More Stock

Simply Wall St.

2 years ago

Independent Director of Unifi Picks Up 28% More Stock

Mama’s Creations, Inc. Announces Proposed Public Offering of Common Stock by Selling Stockholders

GlobeNewswire

2 years ago

Mama’s Creations, Inc. Announces Proposed Public Offering of Common Stock by Selling Stockholders

Business Wire

2 years ago

Templeton Emerging Markets Fund, Inc. ("EMF") Announces Distribution

Jacobs leading takeover of software company as he readies next move

FreightWaves

2 years ago

Jacobs leading takeover of software company as he readies next move

First Guaranty Bancshares, Inc. Declares 122nd Consecutive Quarterly Cash Dividend to Shareholders

GlobeNewswire

2 years ago

First Guaranty Bancshares, Inc. Declares 122nd Consecutive Quarterly Cash Dividend to Shareholders

Shareholders in Brightcove (NASDAQ:BCOV) are in the red if they invested three years ago

Simply Wall St.

2 years ago

Shareholders in Brightcove (NASDAQ:BCOV) are in the red if they invested three years ago

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

Cambium (CMBM) Solution to Boost Connectivity in Rural Areas

Zacks

2 years ago

Cambium (CMBM) Solution to Boost Connectivity in Rural Areas

Business Wire

2 years ago

Templeton Emerging Markets Fund Announces Commitment to Share Repurchases in Response to Fund Discount

NuScale Power Stock Tumbles After Small Nuclear Plant Cancellation

The Wall Street Journal

2 years ago

NuScale Power Stock Tumbles After Small Nuclear Plant Cancellation

Edenbrook Capital, LLC Boosts Stake in Brightcove Inc

GuruFocus.com

2 years ago

Edenbrook Capital, LLC Boosts Stake in Brightcove Inc

Burning Rock Biotech Limited's (NASDAQ:BNR) largest shareholders are individual investors with 29% ownership, institutions own 26%

Simply Wall St.

2 years ago

Burning Rock Biotech Limited's (NASDAQ:BNR) largest shareholders are individual investors with 29% ownership, institutions own 26%

Share on Social Networks: